CEBPA and chronic myelogenous leukemia, BCR-ABL1 positive: Although enhanced activity of C/EBPß can promote differentiation of normal and malignant myeloid precursors, a complete loss of C/EBPß activity might be necessary to disrupt the differentiation potential of CML-BC (chronic myelogenous leukemia blast crisis) progenitors [35].